Schwalen, S.
35  Ergebnisse:
Personensuche X
?
4

Galantamine treatment in Alzheimer's disease with cerebrova..:

Erkinjuntti, T. ; Gauthier, S. ; Bullock, R....
Journal of Psychopharmacology.  22 (2008)  7 - p. 761-768 , 2008
 
?
6

Time course of adverse events most commonly associated with..:

Láinez, M. J. A. ; Freitag, F. G. ; Pfeil, J....
European Journal of Neurology.  14 (2007)  8 - p. 900-906 , 2007
 
?
9

Topiramate 100 mg/day in migraine prevention: a pooled anal..:

Bussone, G. ; Diener, H.-C. ; Pfeil, J..
International Journal of Clinical Practice.  59 (2005)  8 - p. 961-968 , 2005
 
?
10

Experience with topiramate monotherapy in elderly patients ..:

Groselj, J. ; Guerrini, R. ; Van Oene, J....
Acta Neurologica Scandinavica.  112 (2005)  3 - p. 144-150 , 2005
 
?
 
?
13

P4.026 Galantamine prolonged-release formulation permits on..:

Brodaty, H. ; Schwalen, S. ; Gold, M.
European Neuropsychopharmacology.  14 (2004)  - p. S333-S334 , 2004
 
?
15

Anfallsleiden:

, In: Neurologische Therapie,
Besser, R. ; Schwalen, S. - p. 362-433 , 2002
 
1-15